Pacific Biosciences has appointed Jonas Korlach to chief scientific officer, a position previously held by Eric Schadt. Schadt will remain a key scientific advisor to the company.
Korlach was previously scientific fellow at PacBio, supporting commercial development of the PacBio RS system and performing research aimed at developing new applications for the system. He is a co-inventor of single molecule real-time sequencing technology along with Stephen Turner.
Prior to joining PacBio, Korlach was a postdoctoral researcher at Cornell University. He holds a PhD and MS in biochemistry, molecular and cell biology from Cornell; and an MS and BA in biological sciences from Humboldt University in Berlin, Germany.
Michael Rhodes has left his position at Life Technologies to join NanoString Technologies as director of collaboration and applications development, where he will focus on digital gene expression.
Rhodes held various positions at Life Tech, including most recently as senior manager sequencing portfolio. He joined Applied Biosystems in 1999 in the genetic analysis division before the company was acquired by Life Tech.
In his new position, he will report to Joe Beechem, who recently joined NanoString from Life Tech, where he was most recently vice president, head of advanced sequencing and head of global sequencing chemistry, biochemistry, and biophysics.